-
EP2842605
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2842605
| EP2842605 - Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumor cells [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.12.2021 Database last updated on 26.03.2025 | |
| Former | Grant of patent is intended Status updated on 04.02.2021 | ||
| Former | Examination is in progress Status updated on 12.01.2021 | ||
| Former | Grant of patent is intended Status updated on 25.05.2020 | ||
| Former | Examination is in progress Status updated on 03.11.2017 | Most recent event Tooltip | 24.12.2021 | Application deemed to be withdrawn | published on 26.01.2022 [2022/04] | Applicant(s) | For all designated states Sanaclavis Limited 6th Floor, Charles House 108-110 Finchley Road London NW3 5JJ / GB | [2020/03] |
| Former [2016/38] | For all designated states NK-1 IP Limited 5 New Street Square London EC4A 3TW / GB | ||
| Former [2015/21] | For all designated states Antagonista Enekauno, S.L. Alberto Durero 8- 4ª 41018 Sevilla / ES | ||
| Former [2015/10] | For all designated states Munoz Sáez, Miguel Alberto Durero 8-4°A 41018 Sevilla / ES | Inventor(s) | 01 /
Muñoz Sáez, Miguel Alberto Durero 8-4ª 41018 Sevilla / ES | [2015/21] |
| Former [2015/10] | 01 /
see applicant ... | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2015/10] | Carpintero Lopez, Francisco, et al Herrero & Asociados, S.L. Alcalá 35 28014 Madrid / ES | Application number, filing date | 14189674.6 | 10.02.2005 | [2015/10] | Priority number, date | ES20040000424 | 11.02.2004 Original published format: ES 200400424 | [2015/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2842605 | Date: | 04.03.2015 | Language: | EN | [2015/10] | Type: | A3 Search report | No.: | EP2842605 | Date: | 18.03.2015 | [2015/12] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.02.2015 | Classification | IPC: | A61P35/00, A61K31/5377, A61K31/439, A61K31/454, A61K31/496, A61K31/451, A61K31/445, A61K31/4375, A61K38/04 | [2020/21] | CPC: |
A61K31/451 (EP,US);
A61K31/445 (EP,ES,US);
A61K31/4375 (EP,US);
A61K31/439 (EP,US);
A61K31/454 (EP,US);
A61K31/496 (EP,US);
A61K31/5377 (EP,US);
A61K38/046 (EP,US);
A61P35/00 (EP);
Y02A50/30 (EP,US)
(-)
| C-Set: |
A61K38/046, A61K2300/00 (EP,US)
|
| Former IPC [2015/11] | A61P35/00, A61K31/5377 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2015/44] |
| Former [2015/10] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Verwendung nichtpeptidischer NK1-Rezeptorantagonisten zur Herstellung von Apoptose in Tumorzellen | [2015/10] | English: | Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumor cells | [2015/10] | French: | Utilisation d'antagonistes du récepteur NK1 non peptidiques pour la production de l'apoptose dans des cellules tumorales | [2015/10] | Examination procedure | 18.09.2015 | Amendment by applicant (claims and/or description) | 18.09.2015 | Examination requested [2015/44] | 03.11.2017 | Despatch of a communication from the examining division (Time limit: M06) | 17.08.2018 | Reply to a communication from the examining division | 26.05.2020 | Communication of intention to grant the patent | 08.01.2021 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 05.02.2021 | Communication of intention to grant the patent | 14.06.2021 | Fee for grant paid | 14.06.2021 | Fee for publishing/printing paid | 14.06.2021 | Receipt of the translation of the claim(s) | 01.09.2021 | Application deemed to be withdrawn, date of legal effect [2022/04] | 22.09.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2022/04] | Parent application(s) Tooltip | EP05708080.6 / EP1803456 | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 08.01.2021 | Request for further processing filed | 08.01.2021 | Full payment received (date of receipt of payment) Request granted | 19.01.2021 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 17.08.2018 | Request for further processing filed | 17.08.2018 | Full payment received (date of receipt of payment) Request granted | 30.08.2018 | Decision despatched | Fees paid | Renewal fee | 21.10.2014 | Renewal fee patent year 03 | 21.10.2014 | Renewal fee patent year 04 | 21.10.2014 | Renewal fee patent year 05 | 21.10.2014 | Renewal fee patent year 06 | 21.10.2014 | Renewal fee patent year 07 | 21.10.2014 | Renewal fee patent year 08 | 21.10.2014 | Renewal fee patent year 09 | 21.10.2014 | Renewal fee patent year 10 | 16.02.2015 | Renewal fee patent year 11 | 24.02.2016 | Renewal fee patent year 12 | 23.02.2017 | Renewal fee patent year 13 | 26.02.2018 | Renewal fee patent year 14 | 25.02.2019 | Renewal fee patent year 15 | 06.02.2020 | Renewal fee patent year 16 | Penalty fee | Additional fee for renewal fee | 28.02.2021 | 17 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ID]EP0773026 (PFIZER [US]); | [I]WO9854116 (CADUS PHARMACEUTICAL CORP [US]); | [ID]WO0101922 (INNOVA LTD [GB], et al); | [L]EP1803456 (ANTAGONISTA ENEKAUNO S L [ES]); | [T]WO2009124756 (EUROPEAN MOLECULAR BIOLOGY LAB EMBL [DE], et al); | by applicant | US4680283 | WO9516679 | WO9518124 | WO9523798 | EP0773026 | US5972938 | WO0101922 | WO0177100 |